MAZE
Maze Therapeutics, Inc. Common Stock
NASDAQ: MAZE · HEALTHCARE · BIOTECHNOLOGY
$26.58
+3.50% today
Updated 2026-04-30
Market cap
$1.42B
P/E ratio
—
P/S ratio
501.65x
EPS (TTM)
$-3.05
Dividend yield
—
52W range
$8 – $54
Volume
0.9M
Maze Therapeutics, Inc. Common Stock (MAZE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-99.20M | $-86.83M | $75.95M | $-111.94M |
| Capital expenditures | $1.97M | $441000.00 | $1.15M | $794000.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | $6.74M | $8.75M | $9.65M | $16.40M |
| Free cash flow | $-101.17M | $-87.27M | $74.81M | $-112.73M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |